In October 2023, the Company announced completed recruitment of four patients into cohort A of its Phase 1 study of MTX110 (also known as MAGIC-G1 study) (NCT 05324501) in patients with recurrent ...

The 24-week, single-arm, baseline-controlled clinical trial will enrol a total of 40 subjects at various vascular anomaly ...

Therefore, researchers are studying a pharmaceutical alternative – a drug called rapamycin. It was originally developed as an immunosuppressant for organ transplant patients but, like calorie ...

The epilepsy medication sodium valproate is linked to developmental problems in fetuses, but lab studies may now have found a ...

Compared to placebo (dummy medicine), tolvaptan (a class of medicine known as vasopressin 2 receptor antagonists) probably preserves kidney function and slows the increase in total kidney volume; ...

A recent study published in the Journal of Psychopharmacology suggests that psilocybin, the psychoactive compound found in ...

A study reveals that human embryos may possess a dormancy capability similar to that observed in many other mammals, opening ...

Odyssey Therapeutics, Inc., a biotechnology company pioneering next-generation precision immunomodulators for inflammatory diseases, today announced the formation of its Scientific Advisory Board (SAB ...

Dr Samrat Shah, an internal medicine expert at Apollo Spectra Hospital, Pune, explains that Rapamycin is an immunosuppressant ...

It’s unclear how many people are taking rapamycin for its anti-aging properties since the drug is typically taken off-label ...

For a group of people trying to slow aging, a small weekly dose of rapamycin is part of their strategy. They use the drug off ...

Anti-aging enthusiasts are embracing the promise they believe exists in the immune-suppressing drug rapamycin, a generic ...